#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Guillain-Barre syndrome Systemic candida Anaplastic large cell lymphoma T- and null-cell types Ovarian cancer Neurofibroma Craniocerebral injury Facioscapulohumeral muscular dystrophy Activated PI3 kinase delta syndrome Primary adrenal insufficiency Fibrodysplasia ossificans progressiva Paroxysmal nocturnal haemoglobinuria Choroidal dystrophy Hypersensitivity pneumonitis Alpha-1 antitrypsin deficiency Congenital generalised lipodystrophy More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome – Basic Information Cystic fibrosis – Trials in Disease Sarcoma – Basic Information Soft tissue sarcoma – Trials in Disease Leukoencephalopathy – Trials in Disease Pituitary-dependent Cushing’s syndrome – Diagnostics Leiomyosarcoma – Life with Disease Erdheim-Chester disease – Treatment Nephroblastoma – Basic Information Angiosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ARFOLITIXORIN Pervi-Fus Povidone Ublituximab Deucrictibant Oleclumab Io102 Hydrochloride Gadobenate Dimeglumine Chlorphenamine Maleate Glipizide Promazine Hydrochloride Glucose Water For Injection Micronised Spironolactone Magnesium Hydroxide LYSERGIDE Vx-670 Nvdx3 Cl-Ad-Msc-002 Atorvastatin Calcium More therapies…

    Learn about Your Condition

    Sickle cell disease Hereditary optic atrophy Pancreatic neoplasm Malignant melanoma of eyelid Narcolepsy Hypothyroidism Pharyngeal cancer stage III Renal cancer metastatic Immunodeficiency congenital Acute myocardial infarction Double hit lymphoma H1N1 influenza Polymyalgia rheumatica Cardiovascular disorder Infertility More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Phenylketonuria

  • A Study of Repinatrabit Compared to Placebo for Treatment of Patients with Phenylketonuria

    Recruiting

    3 1
    Czechia France Germany Italy The Netherlands Poland +1

  • Study of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • Sepiapterin
    France Ireland Poland Sweden

  • Study on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria

    Not recruiting

    3 1 1
    Investigated Drugs:
    • (S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One
    Czechia Denmark France Germany Italy The Netherlands +4

  • Study Comparing Sepiapterin and Sapropterin for Treating Phenylketonuria in Patients Aged 2 Years and Older

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • (S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One
    • Sapropterin Dihydrochloride
    Czechia Denmark France Germany Italy The Netherlands +3

  • Study of pegvaliase injections compared to diet control in adolescents aged 12-17 with phenylketonuria (PKU)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • Pegvaliase
    Germany

  • Study to Evaluate mRNA-3210 for Safety and Tolerability in Patients with Phenylketonuria

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • Hydroxyzine Hydrochloride
    • Ibuprofen Lysine
    • Mrna-3210
    France Italy Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!